Navigation Links
VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
Date:2/26/2008

SAN FRANCISCO, Feb. 26 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that James G. Stewart, senior vice president, chief financial officer of VIA, will present a company update at the Susquehanna Second Annual SIGnificant Options in Healthcare on Tuesday, March 4, 2008, at 1:30 p.m. ET at the W Hotel in New York. Interested parties may access a live audio webcast of the presentation from the investor section of the VIA website, http://www.viapharmaceuticals.com. A replay of the presentation will be archived on the site for at least one week following the presentation.

Also on March 4, Lawrence K. Cohen, Ph.D., chief executive officer of VIA, will be speaking at the Rodman & Renshaw Straight to the Heart Cardiovascular Investor Mini Conference in Boston, at the Boston Harbor Hotel.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.


'/>"/>
SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Lotus Pharmaceuticals Raises $5 Million in Private Placement
2. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
3. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
4. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
5. RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia
6. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
7. NUCRYST Pharmaceuticals announces year-end results
8. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
9. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
10. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
11. American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...out among thousands of people has shown a clear co...s, leading to osteoporosis and fractures. , Thi...esearchers, Prof. Raz Yirmiya, head of the Brain a...f the Bone Laboratory. They further revealed that ...is particularly strong among young women. , Oste...
(Date:11/9/2009)...Nutrition announced today the acquisition of App T... subsidiary of Natural Nutrition. Natural Nutriti...he company will focus its efforts on the business ...ing mobile application market places throughout em...d on multi platform apps designed to run on device...
(Date:11/9/2009)...r development of scientists and science trainees w...ical medicine, AAAS, Science Careers, and Science ...called CTSciNet, the Clinical and Translational Sc... November 6, 2009 -- Launched October 20 by Scienc...CTSciNet is an online community for people pursui...
(Date:11/9/2009)...rm Bill, The Affordable Health Care for American A...urday Night, and Is Expected to Be Signed into Law...h Absolute Confidence. ERISAclaim.com Announced th...fically for the Compliance with the New Federal He... Hanover Park, IL (PRWEB) November 9, 20...
(Date:11/9/2009)...orporation announces that their design, production... Minneapolis, MN (Vocus) November 9, ...g manufacturer of miniature high-rel connectors, a...ems have been certified to the ISO 9001:2000 (w/de...ystem Standard., , ,The company,s entire quality s...
Breaking Medicine News(10 mins):Health News:Connection between depression and osteoporosis detailed by Hebrew University researchers 2Health News:Social Network for Translational Scientists Launched 2Health News:Social Network for Translational Scientists Launched 3Health News:Social Network for Translational Scientists Launched 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 3Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 5Health News:Omnetics Connector Corporation Achieves AS9100 Certification 2
...alth,programs in Michigan, Ohio, and Indiana are e...e Delta Dental Foundation,s third annual Community...ay by Nancy E. Hostetler,senior vice president of ...ize oral health initiatives.,Special consideration...
...g disorder cuts the danger, one expert says , ...rupted nighttime breathing of sleep apnea appears ...ers report. , Earlier studies have linked sleep ap...the risk is present among all people with obstruct...
...varies greatly for the treatment of men with early...d category of health care facility, suggesting the... standard treatment protocols, according to a new ...est that there is much to do before quality improv...
...y of Pennsylvania School of Medicine have discover... maintain the proper level of bile in the liver. F...at diseases that involve the regulation of bile sa... through ducts to the small intestine where it hel...
...t renowned for enhancing athletic performance and ...s in patients with chronic obstructive pulmonary d...mized, placebo-controlled, double-blind study prov...ence to suggest Cr uptake into muscles [in COPD pa...
...cond year in a row, is giving away $1 million in d...o need it the most. , Nor...year in a row, http://www.youtube.com/watch?v=VgH...away $1 million in discount pharmacy cards to unin...
Other Medicine News:Health News:Delta Dental Foundation Calls for Applicants for Annual Community Mini-Grant Program 2Health News:Sleep Apnea Boosts Death Risk 2Health News:Sleep Apnea Boosts Death Risk 3Health News:Disparities in prostate cancer treatment suggest ways to improve care 2Health News:Penn researchers find a new role for a 'Foxy Old Gene' 2Health News:No substitute for hard work: Creatine supplementation does not improve exercise outcomes in COPD 2Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 2Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 3Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 4
(Date:11/9/2009)...FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SH...any, today announced the availability of INTUNIV...armacies across the United States for the treatmen...DHD ) in children and adolescents ages 6 to 17. ...s the first and only nonscheduled alpha-2A recepto...
(Date:11/9/2009)...all/ -- PAREXEL International Corporation (Nasdaq:...ces provider, today announced that it has enhanced...linical development through an alliance with Morta...butes electrocardiogram (ECG) devices and related ...trument,s Surveyor Telemetry Central System to sup...
(Date:11/7/2009)...wire/ -- Most patients with hereditary angioedema ...ing HAE attack giving the patients sufficient time...associated with that attack, according to survey f...ge of Allergy, Asthma & Immunology (ACAAI) Ann... fatigue and nausea, which occur frequently before...
Breaking Medicine Technology:Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 1Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 2Misonix Inc Announces the Sale of Sonora Medical Systems for 248 Million 5218 1Misonix Inc Announces the Sale of Sonora Medical Systems for 248 Million 5218 2Misonix Inc Announces the Sale of Sonora Medical Systems for 248 Million 5218 3Facilitation Payments Seen as Problematic by Many Companies 5215 1Facilitation Payments Seen as Problematic by Many Companies 5215 2Facilitation Payments Seen as Problematic by Many Companies 5215 3Facilitation Payments Seen as Problematic by Many Companies 5215 4
...PHIS, Tenn., Sept. 10 As a surgeon and clinical,i...firsthand about the,growing number of patients con...Infections. He was also keenly aware that infectio...tem into schools, gyms, prisons and,retirement hom...13,510 admissions at an,accredited 450-bed regiona...
...TIN, Texas, Sept. 10 The first-ever human,clinica...bal tea was,recently conducted, testing whether th...r disease., The new trial also generated the firs... environment, scientifically showing that,short-te...r and kidneys,while keeping various blood paramete...
Other Medicine Technology:Doctor Declares War on Hospital Infections, Patents MRSA-Killing Machine 2Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 2Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 3Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 4Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 5
...r the control of glucose metabolism. It is synthe...s the precursor, proinsulin, which is processed to... equimolar amounts into the portal circulation. T...ypeptide chains, the A-chain and B-chain (21 and 3...
...reatic -cell function is not only of use in the pr...y of diabetes mellitus, but is also relevant in cl...f treatment. Peripheral insulin levels cannot be u...and variable uptake from the portal circulation in...
...eimmunoassay for the quantitation of 25-OH D and o...Calibrators, controls and samples are diluted with...incubated in microtitre wells which are coated wit...ours at room temperature before aspiration and was...
...r the control of glucose metabolism. It is synthe...s the precursor, proinsulin, which is processed to... equimolar amounts into the portal circulation. T...ypeptide chains, the A-chain and B-chain (21 and 3...
Medicine Products: